A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

A Protocol for Multidisciplinary Rehabilitation Combined with Enzyme Replacement Therapy for Ventilator Weaning in Late-Onset Pompe Disease

126 views

⸱

DOI:

10.3791/70063

⸱

August 11th, 2026

 ,  ,  , 

* These authors contributed equally

In This Article

Summary

This protocol describes a multidisciplinary rehabilitation approach integrated with enzyme replacement therapy to support ventilator weaning in a patient with late-onset Pompe disease through structured respiratory training, physical rehabilitation, nutritional management, psychological support, and standardized extubation assessment.

Abstract

Late-onset Pompe disease (LOPD) is a rare autosomal recessive lysosomal storage disorder caused by acid alpha-glucosidase deficiency, resulting in progressive skeletal and respiratory muscle weakness that may lead to chronic respiratory insufficiency and prolonged dependence on mechanical ventilation. Although enzyme replacement therapy (ERT) can slow disease progression, successful ventilator weaning often requires coordinated multidisciplinary management. This protocol describes a reproducible rehabilitation approach integrated with ERT to support ventilator weaning and extubation in patients with LOPD. The method combines pharmacological treatment with structured respiratory rehabilitation, physical training, nutritional management, psychological support, and traditional Chinese medicine–based interventions, including auricular acupuncture and seated Tai Chi. The protocol also incorporates standardized assessment procedures, individualized treatment planning, ventilator weaning strategies, and objective criteria for evaluating extubation readiness. Emphasis is placed on collaboration among physicians, rehabilitation therapists, nurses, nutritionists, and psychologists to address the complex needs of patients with neuromuscular respiratory impairment. The approach is illustrated through its application in an adult patient with LOPD who required prolonged mechanical ventilation. This protocol provides a practical framework that may be adapted across clinical settings to support respiratory recovery, rehabilitation participation, and ventilator weaning in patients with LOPD and related neuromuscular disorders.

Introduction

Pompe disease is a rare autosomal recessive lysosomal storage disorder caused by pathogenic variants in the acid alpha-glucosidase (GAA) gene. The resulting deficiency of lysosomal GAA impairs glycogen degradation and leads to progressive glycogen accumulation, particularly in skeletal, cardiac, and respiratory muscles. The reported frequency of Pompe disease varies among populations and according to the methods used for case identification. In a nationwide Belgian cohort, the prevalence of late-onset Pompe disease (LOPD) was estimated at 3.9 cases per million individuals1.

Pompe disease is generally classified into ....

Access restricted. Please log in or start a trial to view this content.

Protocol

Conduct all procedures involving the patient in accordance with the Declaration of Helsinki and the requirements of the Institutional Research Ethics Committee of the Third Affiliated Hospital of Zhejiang Chinese Medical University (Approval No. ZSLL-ZN-2024-039-01). This protocol was developed from and implemented in the representative adult patient with confirmed LOPD described above. Obtain written informed consent from the patient or the patient’s legally authorized representative for treatment, study-related data collection, and publication of de-identified clinical information before protocol implementation.

1. Patient Pre....

Access restricted. Please log in or start a trial to view this content.

Results

Representative Baseline Clinical Profile

Before transfer, the patient developed inability to expectorate airway secretions at home, followed by cardiopulmonary arrest. He was resuscitated at a local hospital and transferred to a higher-level surgical intensive care unit. Before rehabilitation admission, he had received alglucosidase alfa, piperacillin sodium and sulbactam sodium, enoxaparin sodium, acid-suppression therapy, expectorant treatment, and intermittent bronchoscopic.......

Access restricted. Please log in or start a trial to view this content.

Discussion

ERT remains the disease-specific biochemical foundation for Pompe disease because it increases exogenous GAA availability and reduces lysosomal glycogen accumulation. However, published evidence demonstrates that the clinical response in LOPD is heterogeneous, and respiratory weakness may remain a major determinant of ventilator dependence despite continued ERT42. This observation explains why the present protocol did not treat ERT as a standalone solution. Instead, ERT was combined with respirato.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare that they have no competing financial interests or personal relationships that could have influenced the work reported in this article.

Acknowledgements

This work was supported by the XinMiao Talent Plan of the Third Affiliated Hospital of Zhejiang Chinese Medical University (Grant No. 2023XMRC01; Principal Investigator: Wei Wang) and the Hospital-Level Basic Public Welfare Research and Cultivation Project (Grant No. ZS21ZA02; Principal Investigator: Xiaomeng Liu). The authors thank all members of the multidisciplinary rehabilitation team for their valuable contributions to the clinical implementation of this protocol.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
0.9% sodium chloride injectionBaxter or equivalent hospital-grade sterile infusion fluidN/AUsed for dilution of reconstituted alglucosidase alfa before IV infusion.
3 L calibration syringeVitalographModel 2040; catalog no. 36020Calibration verification for spirometry or flow/volume measurement equipment.
4-Methylumbelliferyl alpha-D-glucopyranosideSigma-Aldrich / MerckM9766Fluorogenic substrate for acid alpha-glucosidase activity assay.
AcarboseSigma-Aldrich / MerckA8980Inhibitor used to suppress maltase-glucoamylase interference during acid alpha-glucosidase activity testing.
Airway management/reintubation kitInstitutional emergency airway cartN/AIncludes laryngoscope/video laryngoscope, endotracheal tubes, stylet, suction catheter, bag-valve-mask, oxygen source, and emergency medications according to institutional policy.
Alglucosidase alfaSanofi / GenzymeMyozyme or Lumizyme; 50 mg vialEnzyme replacement therapy; 20 mg/kg IV every 2 weeks; administer with stepwise infusion-rate escalation according to product label.
Antiseptic skin preparation swabsEmbecta / BDBD Alcohol Swabs; 32689570% isopropyl alcohol swabs for auricular skin preparation before needle insertion.
Auricular acupuncture needlesTCMSupplyE-S 240901Single-use sterile auricular acupuncture needles for Shenmen, Heart, and Sympathetic points. 
Bag-valve-mask deviceInstitutional emergency airway cartN/AEmergency ventilation support during airway or infusion-related deterioration.
Barthel IndexPublicly available clinical instrumentN/AFunctional status assessment.
Bedside multiparameter monitorShenzhen Mindray Bio-Medical Electronics Co., Ltd.iMEC8Continuous monitoring of ECG, heart rate, respiratory rate, non-invasive blood pressure, SpO2, and temperature.
Berg Balance ScalePublicly available clinical instrumentN/ABalance assessment; score range 0–56.
Biological microscopeMINGHUINE710Muscle-biopsy histopathology review and calibrated image acquisition.
Blood gas analyzerRadiometer Medical ApSABL90 FLEXArterial blood gas analysis, including pH, PaO2, PaCO2, bicarbonate, base excess, and lactate.
Borg Category-Ratio 10 scalePublicly available clinical instrumentN/APerceived exertion and dyspnea-related exertional tolerance monitoring.
Bristol Stool Form ScalePublicly available clinical instrumentN/AStool-consistency assessment during bowel-function monitoring.
Case report form / MDT documentation templateInstitution-developed formN/AUsed to record protocol adherence, outcomes, adverse events, deviations, and follow-up data.
EDTA blood collection tubeBD Vacutainer or equivalentN/APeripheral blood collection for leukocyte acid alpha-glucosidase activity testing and GAA molecular testing.
Electric suction apparatusYuwell7A-23DAirway secretion suction; 20 L/min suction-capacity model suitable for hospital secretion management.
Emergency medications for anaphylaxisInstitutional emergency medication supplyN/AIncludes epinephrine, antihistamine, corticosteroid, bronchodilator, and isotonic crystalloid according to institutional policy.
Enteral feeding pumpMDKMed Medical Technology Co., Ltd.ME11Continuous enteral nutrition pump for controlled infusion of nutritional solutions.
Enteral feeding tubeHospital-approved supplierN/ANasogastric or nasoenteric tube for enteral nutrition when clinically required. 
Enteral nutrition formulaHospital-approved supplierN/AFormula selected by dietitian according to energy/protein targets and gastrointestinal tolerance. 
GAD-7 questionnairePublicly available clinical instrumentN/AAnxiety assessment.
Genomic DNA extraction kitQIAGENQIAamp DNA Blood Mini Kit; 51104 or 51106Extraction of genomic DNA from peripheral blood leukocytes for GAA sequencing.
Hand weightsCanDo / Fabrication EnterprisesCanDo vinyl-coated dumbbellsLow-load progressive resistance training for upper-limb strengthening.
High-flow oxygen systemFisher & Paykel HealthcareAIRVO 2Optional post-extubation high-flow nasal oxygen support; flow range 2–60 L/min.
High-protein oral nutritional supplementAbbott LaboratoriesEnsure Plus or equivalentOral nutritional support when swallowing and gastrointestinal tolerance permit.
High-throughput sequencing platformMGI Tech Co., Ltd.MGISEQ-2000Sequencing platform used for GAA molecular testing.
Infusion pumpShenzhen Mindray Bio-Medical Electronics Co., Ltd.BeneFusion VP1 ExControlled ERT administration through programmable infusion pump.
Inline infusion filterB. BraunSterifix 0.2 μm infusion filter0.2 μm low-protein-binding in-line filter for alglucosidase alfa administration.
Inspiratory muscle training devicePhilips RespironicsThreshold IMT; HS730Threshold-loading inspiratory muscle trainer for respiratory muscle strengthening.
Intensive Care Unit Mobility ScalePublicly available clinical instrumentN/AMobility-level assessment during rehabilitation.
Invasive ventilatorShenzhen Comen Medical Instruments Co., Ltd.COMEN V3AUsed for invasive ventilatory support; representative patient was ventilated in p-SIMV mode on admission.
Low-protein-binding infusion extension setBecton, Dickinson and Company (BD)SmartSite Extension Set, 0.2 micron filter; product code 20027ELow-protein-binding extension set used for filtered IV infusion when available.
Mechanical insufflation-exsufflation devicePhilips RespironicsCoughAssist E70; catalog/model 1098163 or 1098159Used for assisted cough and secretion clearance when cough effectiveness remains inadequate or peak cough flow is severely reduced.
Medical Research Council muscle-strength scalePublicly available clinical instrumentN/AMuscle-strength grading and MRC sum score calculation.
Microscope cameraMINGHUIMHS900 cameraDigital pathology image capture for representative histopathology images.
Non-invasive ventilation systemResMedStellar 150Used for post-extubation or weaning support when NIV is clinically required.
Nose clipGVSDisposable nose clip; product line: Accessories for SpirometryUsed during respiratory mechanics testing when a mouthpiece method is feasible.
Periodic acid-Schiff staining systemSigma-Aldrich / Merck395B-1KTPAS staining of muscle-biopsy sections to demonstrate glycogen accumulation.
PHQ-9 questionnairePublicly available clinical instrumentN/ADepression assessment.
Pulmonary function / peak-flow measurement deviceZhejiang E-Linkcare Meditech Co., Ltd. / figure-materials-1PF680Used for pulmonary-function assessment and peak expiratory/cough-flow-related measurement; records FVC, FEV1, PEF, and related spirometric parameters.
Respiratory pressure meter for MIP/MEPXEEKX1Used for maximal inspiratory pressure and maximal expiratory pressure measurement.
Respiratory testing maskAmbuAmbu Disposable Face Mask; adult size selected according to patient fitMask interface for respiratory testing or airway support when a mouthpiece cannot be used.
Respiratory testing mouthpieceGVSErgonomic spirometry mouthpiece; product line: Accessories for SpirometrySingle-patient-use mouthpiece for spirometry or respiratory mechanics testing.
Resistance bandsTHERABANDProfessional latex or non-latex resistance bandsProgressive resistance exercises; select resistance level according to therapist assessment.
Richmond Agitation-Sedation ScalePublicly available clinical instrumentN/ASedation and arousal assessment before psychological or functional assessment.
Secure electronic medical record or research-data systemInstitutional systemN/AUsed for secure storage of source documents, study records, audit trails, and de-identified research data.
Sharps disposal containerBD or equivalent medical sharps-disposal supplierN/ARigid puncture-resistant sharps container for immediate disposal of used acupuncture needles.
Stable armless chairHospital-approved rehabilitation equipment supplierN/AUsed for 30-s chair-stand test; chair height approximately 43–45 cm.
Sterile water for injectionBaxter or equivalent hospital-grade sterile diluentN/AUsed for reconstitution of alglucosidase alfa according to manufacturer’s instructions.
Stopwatch/timerHospital-approved supplierN/AUsed for SBT timing, respiratory-training intervals, exercise sessions, Tai Chi sessions, and monitoring intervals.
Tai Chi instructional materialsDr. Paul Lam Tai Chi Productions or institution-developed seated Tai Chi protocolN/AUsed to standardize seated Tai Chi movement sequence and breathing coordination.
Transfer aidArjoSara StedySit-to-stand and transfer support during early mobilization and standing practice.
Whole-chest oscillation sputum-clearance deviceChangzhou Siya Medical Device Co., Ltd. / YasiYSQ01BWhole-chest oscillation airway-clearance device used for secretion mobilization and sputum clearance.

References

  1. Vanherpe P, et al. Late-onset Pompe disease (LOPD) in Belgium: clinical characteristics and outcome measures. Orphanet J Rare Dis. 2020;15:83.
  2. Sperry E, Leslie N, Berry L, Pena L. Pompe disease. In: GeneReviews®. University of Washington; Seattle; 2007.
  3. Kishnani PS, et al. Pompe disease diagnosis and management guideline. Genet Med. 2006;8:267-88.
  4. Toscano A, Rodolico C, Musumeci O. Multisystem late onset Pompe disease (LOPD): an update on clinical aspects. Ann Transl Med. 2019;7:284.
  5. Spiesshoefer J, et al. The nature of respiratory muscle weakness in patients with late-onset Pompe disease. Neuromuscul Disord. 2019;29:618-27.
  6. Sh....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Respiratory Muscle WeaknessMechanical VentilationRespiratory RehabilitationPhysical TrainingNutritional ManagementAuricular Acupuncture